SCHEMBL7300880

SCHEMBL7300880

CCOC(=O)Nc1ccc(C2CCN(OC(=O)OCC)CC2)cc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.49
MAPT P10636 2/20 0.46
MAPK1 P28482 1/20 0.45
SLC18A3 Q16572 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.44
HPGD P15428 2/20 0.44
CYP1A2 P05177 2/20 0.44
NPC1 O15118 2/20 0.44
RAB9A P51151 2/20 0.44
CRHBP P24387 1/20 0.44
CRHR2 Q13324 1/20 0.44
ABL1 P00519 1/20 0.42
POLB P06746 1/20 0.42
RIN1 Q13671 1/20 0.42
TDP1 Q9NUW8 1/20 0.42
KMT2A Q03164 1/20 0.42
MMP2 P08253 1/20 0.42
MMP9 P14780 1/20 0.42
MMP8 P22894 1/20 0.42
MMP14 P50281 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7305192 0.90 NAMPT (0.47) LMNAMAPTMAPK1SLC18A3SMN1; SMN2
SCHEMBL27322968 0.88 LMNA (0.47) LMNAMAPTMAPK1SLC18A3HPGD
SCHEMBL8986471 0.84 MAPT (0.58) LMNAMAPTHPGDABL1POLB
SCHEMBL10813817 0.80 LMNA (0.61) LMNASMN1; SMN2HPGDCYP1A2NPC1
SCHEMBL8986418 0.80 LMNA (0.61) LMNASMN1; SMN2HPGDCYP1A2NPC1
SCHEMBL8986417 0.78 NAMPT (0.65) LMNAMAPTMAPK1NPC1RAB9A
SCHEMBL27319005 0.76 SLC18A3 (0.47) LMNAMAPTSLC18A3SMN1; SMN2HPGD
SCHEMBL1996211 0.74 NAMPT (0.57) LMNAMAPTSMN1; SMN2NPC1RAB9A
SCHEMBL1996214 0.74 NAMPT (0.57) LMNAMAPTSMN1; SMN2NPC1RAB9A
SCHEMBL7565510 0.73 RAB9A (0.71) LMNAMAPTMAPK1SMN1; SMN2HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0657440-B1 Oxazolidine-2-one derivatives as MAO inhibitors HOFFMANN LA ROCHE (CH) 2000-04-05 EP disclosed
EP-0657440-A1 Oxazolidine-2-one derivatives F. HOFFMANN-LA ROCHE AG (CH) 1995-06-14 EP disclosed